Safety and Immunogenicity of mRNA Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Lung Cancer Receiving Immune Checkpoint Inhibitors: A Multicenter Observational Study in Japan
Makoto Hibino, Kiyoaki Uryu, Takayuki Takeda, Yusuke Kunimatsu, Shinsuke Shiotsu, Junji Uchino, Soichi Hirai, Tadaaki Yamada, Asuka Okada, Yoshikazu Hasegawa, Osamu Hiranuma, Yusuke Chihara, Riko Kamada, Shunichi Tobe, Kazunari Maeda, Shigeto Horiuchi, Tetsuri Kondo, Koichi Takayama
Topics & Concepts
MedicineImmunogenicityLung cancerObservational studyImmune systemCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CancerImmunologyInternal medicineDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses